Leqembi Set For Japan Launch After Twisty Pricing Process

Close Monitoring Under Conditional Approval

 
• By Lisa Takagi
  
Eisai has faced tough pricing negotiation with the MHLW for lecanemab, although both sides recognize its value.
Eisai faced tough Japan price negotiations for Leqembi, but both sides recognized value • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Japan

More from Asia